IMD-0560
featured

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 564853

CAS#: 439144-66-8

Description: IMD-0560 is an IKK inhibitor which suppresses heart failure and chronic remodeling after myocardial ischemia via MMP alteration.


Chemical Structure

img
IMD-0560
CAS# 439144-66-8

Theoretical Analysis

MedKoo Cat#: 564853
Name: IMD-0560
CAS#: 439144-66-8
Chemical Formula: C15H8BrF6NO2
Exact Mass: 426.96
Molecular Weight: 428.130
Elemental Analysis: C, 42.08; H, 1.88; Br, 18.66; F, 26.63; N, 3.27; O, 7.47

Price and Availability

Size Price Availability Quantity
5mg USD 350 2 Weeks
25mg USD 950 2 Weeks
Bulk inquiry

Synonym: IMD0560; IMD 0560; IMD-0560

IUPAC/Chemical Name: N-[2,5-Bis(trifluoromethyl)phenyl]-5-bromo-2-hydroxybenzamide

InChi Key: SVGRIJCSKWXOPA-UHFFFAOYSA-N

InChi Code: InChI=1S/C15H8BrF6NO2/c16-8-2-4-12(24)9(6-8)13(25)23-11-5-7(14(17,18)19)1-3-10(11)15(20,21)22/h1-6,24H,(H,23,25)

SMILES Code: O=C(NC1=CC(C(F)(F)F)=CC=C1C(F)(F)F)C2=CC(Br)=CC=C2O

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >3 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 428.13 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Sawada I, Hashimoto K, Sawada K, Kinose Y, Nakamura K, Toda A, Nakatsuka E, Yoshimura A, Mabuchi S, Fujikawa T, Itai A, Kimura T. The Novel IκB Kinase β Inhibitor, IMD-0560, Has Potent Therapeutic Efficacy in Ovarian Cancer Xenograft Model Mice. Int J Gynecol Cancer. 2016 May;26(4):610-8. doi: 10.1097/IGC.0000000000000668. PubMed PMID: 26905334.

2: Toda A, Sawada K, Fujikawa T, Wakabayashi A, Nakamura K, Sawada I, Yoshimura A, Nakatsuka E, Kinose Y, Hashimoto K, Mabuchi S, Tokuhira A, Nakayama M, Itai A, Kurachi H, Kimura T. Targeting Inhibitor of κB Kinase β Prevents Inflammation-Induced Preterm Delivery by Inhibiting IL-6 Production from Amniotic Cells. Am J Pathol. 2016 Mar;186(3):616-29. doi: 10.1016/j.ajpath.2015.11.004. Epub 2016 Jan 12. PubMed PMID: 26796146.

3: Tada Y, Kokabu S, Sugiyama G, Nakatomi C, Aoki K, Fukushima H, Osawa K, Sugamori Y, Ohya K, Okamoto M, Fujikawa T, Itai A, Matsuo K, Watanabe S, Jimi E. The novel IκB kinase β inhibitor IMD-0560 prevents bone invasion by oral squamous cell carcinoma. Oncotarget. 2014 Dec 15;5(23):12317-30. PubMed PMID: 25373602; PubMed Central PMCID: PMC4322973.

4: Orita S, Miyagi M, Kobori S, Gemba T, Ishikawa T, Inoue G, Toyone T, Aoki Y, Eguchi Y, Takahashi K, Ohtori S. IκB kinase β inhibitor downregulates pain-related neuropeptide production in the sensory neurons innervating injured lumbar intervertebral discs in the dorsal root ganglia of rats. Spine J. 2013 Mar;13(3):284-8. doi: 10.1016/j.spinee.2013.01.020. Epub 2013 Feb 23. PubMed PMID: 23462514.

5: Wakatsuki S, Suzuki J, Ogawa M, Masumura M, Muto S, Shimizu T, Takayama K, Itai A, Isobe M. A novel IKK inhibitor suppresses heart failure and chronic remodeling after myocardial ischemia via MMP alteration. Expert Opin Ther Targets. 2008 Dec;12(12):1469-76. doi: 10.1517/14728220802551140 . PubMed PMID: 19007316.

6: Okazaki Y, Sawada T, Nagatani K, Komagata Y, Inoue T, Muto S, Itai A, Yamamoto K. Effect of nuclear factor-kappaB inhibition on rheumatoid fibroblast-like synoviocytes and collagen induced arthritis. J Rheumatol. 2005 Aug;32(8):1440-7. PubMed PMID: 16078317.